|
Loading...
| ||||||||||||||
Recent Publications by Pfizer Global Research and Development: |  | |
| 5-Nitro-2-(3-Phenylpropylamino)benzoic Acid Is a GPR35 Agonist.
GPR35 is a G(i/o)- and G(16)-coupled receptor abundantly expressed in... | Discovery Biology Research, Pfizer Global Research and Development, Nagoya | Pharmacology. 2008 Sep 26;82(4):245-249.
DOI Direct Link |
| 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: A novel series of mGluR2 positive allosteric modulators.
The synthesis and structure-activity relationship (SAR) of a novel series... | Pfizer Global Research and Development, Groton Laboratories, Eastern Point | Bioorg Med Chem Lett. 2008 Sep 10.
DOI Direct Link |
| Small, non-peptide C5a receptor antagonists: Part 1.
The optimisation of a series of amides for C5a receptor binding and... | Department of Discovery Chemistry, Pfizer Global Research and Development, | Bioorg Med Chem Lett. 2008 Aug 31.
DOI Direct Link |
| Small, non-peptide C5a receptor antagonists: Part 2.
Starting from 2, several highly potent C5a receptor antagonists were... | Department of Discovery Chemistry, Pfizer Global Research and Development, | Bioorg Med Chem Lett. 2008 Aug 31.
DOI Direct Link |
| Reduction of in-source collision-induced dissociation and thermolysis of sulopenem prodrugs for quantitative liquid chromatography/electrospray ionization mass spectrometric analysis by promoting sodium adduct formation.
Six chromatographically resolved sulopenem prodrugs were monitored for... | Pharmacokinetics, Dynamics & Metabolism, Pfizer Global Research and | Rapid Commun Mass Spectrom. 2008 Sep 22;22(20):3195-3206.
DOI Direct Link |